Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Meloxicam clinical data on a preferential cyclooxygenase-2 inhibitorM DistelBiomedical Sciences Instrumentation|January 1, 1997
Development of an underwater weighing system for determining body compositionP E Patterson, M DistelPM & R : the Journal of Injury, Function, and Rehabilitation|June 28, 2011
Prolotherapy: a clinical review of its role in treating chronic musculoskeletal painLaura M Distel, Thomas M BestBritish Journal of Rheumatology|April 1, 1996
Meloxicam in osteoarthritis: a 6-month, double-blind comparison with diclofenac sodiumJ Hosie, M Distel, E BluhmkiBritish Journal of Rheumatology|April 1, 1996
A double-blind study to compare the efficacy and safety of meloxicam 15 mg with piroxicam 20 mg in patients with osteoarthritis of the hipB Lindén, M Distel, E BluhmkiScandinavian Journal of Rheumatology|March 20, 1998
A double-blind, randomized, placebo-controlled study of efficacy and tolerance of meloxicam treatment in patients with osteoarthritis of the kneeB Lund, M Distel, E BluhmkiBritish Journal of Rheumatology|April 1, 1996
A double-blind, three-week study to compare the efficacy and safety of meloxicam 7.5 mg and meloxicam 15 mg in patients with rheumatoid arthritisJ Y Reginster, M Distel, E BluhmkiBritish Journal of Rheumatology|April 1, 1996
Safety of meloxicam: a global analysis of clinical trialsM Distel, C Mueller, E Bluhmki, et al.The Physician and Sportsmedicine|April 29, 2010
Safety baseballs and chest protectors: a systematic review on the prevention of commotio cordisJustin A Classie, Laura M Distel, James R BorchersClinical Therapeutics|May 1, 1996
Evaluation of the safety, tolerability, and efficacy of meloxicam tablets in patients with osteoarthritisP J Prouse, P J Bevis, E Bluhmki, et al.Pageof 2